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Vascular dementia is the second most common cause of dementia. Physical disability and
cognitive impairment due to stroke are conditions that considerably affect quality of life. We
estimated the prevalence and incidence of possible vascular dementia (PVD) in older adults
using data from the Mexican Health and Aging Study (MHAS 2012 and 2015 waves).
Methods
The MHAS is a representative longitudinal cohort study of Mexican adults aged�50 years.
Data from 14, 893 participants from the 2012 cohort and 14,154 from the 2015 cohort were
analyzed to estimate the prevalence and incidence of PVD. Self-respondents with history of
stroke were classified as PVD if scores in two or more cognitive domains in the Cross-Cul-
tural Cognitive Examination were� 1.5 standard deviations below the mean on reference
norms and if limitations in� 1 instrumental activities of daily living were present. For proxy
respondents with history of stroke, we used a score�3.4 on the Informant Questionnaire on
Cognitive Decline in the Elderly. Crude and standardized rates of prevalent and incident
PVD were estimated.
Results
Prevalence of PVD was 0.6% (95% CI, 0.5–0.8) (0.5 with age and sex- standardization).
Rates increased with age reaching 2.0% among those aged 80 and older and decreased
with educational attainment. After 3.0 years of follow-up, 87 new cases of PVD represented
an overall incident rate of 2.2 (95% CI, 1.7–2.6) per 1,000 person-years (2.0 with age and
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sex- standardization). Incidence also increased with advancing age reaching an overall rate
of 9.4 (95% CI, 6.3–13.6) per 1,000 person-years for participants aged >80 years. Hyperten-
sion and depressive symptoms were strong predictors of incident PVD.
Conclusion
These data provide new estimates of PVD prevalence and incidence in the Mexican popula-
tion. We found that PVD incidence increased with age. Males aged 80 years or older
showed a greater incidence rate when compared to females, which is comparable to previ-
ous estimates from other studies.
Introduction
Vascular Cognitive Impairment (VCI) is the second most common cause of dementia, with
15% of dementia cases [1]. Post-stroke physical disability and cognitive impairment are condi-
tions that considerably affect quality of life. [2]. When compared to Alzheimer’s disease (AD),
individuals with vascular dementia (VaD) had a higher level of disability and considerably
higher rates of cerebrovascular disease, congestive heart failure, hemiplegia, paraplegia, and
myocardial infarction, thus increasing both the complexity and costs of management of the
disease [3]. Moreover, patients with VaD have been found to have a higher relative risk of
death (RR: 2.7, 95% CI, 1.9–3.9) when compared to AD (RR: 1.4, 95% CI, 1.2–1.7) [4]. Inter-
ventions that target potentially modifiable risk factors associated with VCI [5], such as mini-
mizing diabetes, hypertension treatment, and avoiding midlife obesity, among others, have
been proposed as a way of reducing dementia in low- and middle-income countries [6].
There has been a significant increase of stroke burden in the world especially in developing
countries [7]. In addition, the number of people with dementia in Latin American countries is
predicted to increase 4-fold in the next 30–35 years [8]. Globally, VaD prevalence estimates
range between 0.9 and 3.3% (95% CI, 2.2–4.5) [9]. In developing countries, these estimates
vary from 0.7 (95% CI, 0.1–1.3) to 2.1% (95% CI, 1.6–2.7) in those aged over 55 years [10]. In
Mexico, the Fogarty Stroke Cohort Study, which recruited relatively young acute post-stroke
patients, found a dementia prevalence of 12% three months after stroke [11].
Epidemiological studies report a VaD incidence stratified by age and gender that ranges
from 0.99 (95% CI, 0.96–1.02) [12] to 3.4 (95% CI, 2.1–4.9)/1000 person-years [13]. A meta-
analysis reported varying rates of post-stroke dementia that ranged from 7.4% in population-
based studies of first-ever stroke in individuals with no previous dementia to 41.3% in hospi-
tal-based studies of recurrent stroke in which previous dementia diagnosis was included [5]. A
greater age-adjusted incidence rate (per 1000 person-years) for VaD has been found in men
(12.2) vs women (9.0), along with an increased relative risk with advancing age (RR: 1.6 (95%
IC 1.2–2.0) [14].
VCI frequencies and incidence rates have been reported with great variability possibly
because of different settings and designs, as well as some studies’ neuroimaging accessibility
[4, 10, 15]. Specific criteria involving the temporal relationship between a vascular event and
the onset of cognitive decline is also to be considered when accounting for differences between
studies [15]. Still, experts have been making progress in producing guidelines for a more stan-
dardized diagnosis [16, 17], where an umbrella of diagnostic possibilities for VaD is consid-
ered. Even if the use of magnetic resonance imaging (MRI) is a gold standard requirement for
clinical diagnosis, a definition of possible mild or major VCI (VaD) is appropriate when
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neuroimaging is not available and clinically significant cognitive deficits in at least one cogni-
tive domain with or without functional dependence are present [17].
Epidemiological investigation ought to be a first step in the means of attracting attention to
dementia subtypes, especially in Latin America, where limited data for stroke and VaD exists
[11, 13]. Therefore, the aim of this study is to determine the prevalence and incidence of PVD
in older adults using a national representative panel study in Mexico, the Mexican Health and
Aging Study (MHAS 2012–2015 waves).
Materials and methods
Study population
The study population included participants from the MHAS [18], a national representative
panel study of Mexican residents aged�50 years with four follow-up waves (2003, 2012, 2015,
2018) of the baseline conducted in 2001. The aim and methodological design of the MHAS is
published elsewhere [19]. We analyzed data from the third and fourth MHAS waves collected
between October 2012 and December 2015. For ethical approval, the MHAS protocols and
instruments were reviewed by the Institutional Review Board of the University of Texas Medi-
cal Branch, the National Institute of Statistics and Geography (INEGI for its acronym in Span-
ish) and the National Institute of Public Health (INSP) in Mexico. MHAS data files and
documentation are of public use and available at www.mhasweb.org.
Sample selection at baseline and follow-up
Fig 1 shows the flowchart of the baseline sample selection from MHAS 2012 wave. A total of
n = 14,893 participants aged 50 or older were included. Individuals who answered the inter-
view directly (self-respondents) represented 91.7% (n = 13,651) of the sample, while 8.3%
(n = 1,242) were proxy respondents. Based on self-reported history of stroke, we identified
n = 338 (2.2%) individuals with stroke and n = 14,552 (97.8%) without stroke. All individuals
were further classified as with dementia or cognitively normal based on diagnostic criteria fur-
ther described.
Fig 2 shows the flowchart of the sample selection at follow-up from the MHAS 2015. Partic-
ipants were followed an average of 3 years (SD = 0.61). During follow-up n = 837 (5.9%) indi-
viduals died (“decedents”), n = 311 (2.2%) refused to answer (“refusals”), and n = 578 (4.1%)
could not be contacted (“lost”). The total follow-up sample comprised n = 12,427 (87.8%) indi-
viduals, including n = 202 with a history of stroke at baseline, n = 172 new cases of stroke, and
n = 12,053 without stroke. Finally, individuals from each group were classified as with demen-
tia or cognitively normal according to the diagnostic criteria further described.
Cognitive assessment
For self-respondents, the MHAS assesses cognitive function through a modified version [20]
of the Cross-Cultural Cognitive Examination (CCCE) [21], which measures performance in
eight cognitive domains—verbal learning, delayed memory, attention, constructional praxis,
visual memory, verbal fluency, orientation, and processing speed—and has reference norms
by age and education. Imputed data were used on cognitive performance for individuals with
missing values using a multivariate, regression-based procedure applied by the MHAS team
following the same methodology as the Health and Retirement Study [22]. For respondents
interviewed by proxy, the MHAS uses a brief version of the Informant Questionnaire on Cog-
nitive Decline in the Elderly (IQCODE) [23]. Proxy interviews are done through an informant,
usually a spouse of a close relative when the selected participant is absent or is not healthy
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enough to complete a direct interview. Self-respondents were classified as having overall
dementia if in at least two cognitive domains [24], scores were� 1.5 standard deviations (SD)
below the mean based on norms by age and education and also had difficulty performing at
least one instrumental activity of daily living (IADL). IADLs included the ability to prepare a
meal, go shopping, manage money, or take medications. Pondering the effect of gender on
some of the IADLs for the Mexican population (e.g., men do not usually prepare a meal and
women do not manage money), individuals that needed help in 1 or more IADL were consid-
ered as functionally impaired.
Fig 1. Flowchart of sample selection at baseline (MHAS 2012).
https://doi.org/10.1371/journal.pone.0253856.g001
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Cognitive performance in those classified as cognitively normal, was no more than one SD
below norms in all cognitive domains or�1.5 SD below in only one domain, and no IADL
limitations were present. For responses collected via proxy-interview, we classified individuals
as having overall dementia if IQCODE scores were� 3.4 and< 3.4 for cognitively normal
individuals, as recommended [25].
History of stroke
Participants were classified as having a stroke history based on the question: Have you ever
been diagnosed with stroke by a doctor? at baseline and follow-up. To correct for possible
response bias, we also selected only those individuals who also at least reported one of the fol-
lowing conditions: focal symptoms of stroke (inability to move arms/legs, difficulty speaking/
eating, difficulty with sight/vision, difficulty thinking/expressing him/herself), received reha-
bilitation therapy or took medications for stroke.
Diagnostic categories
For this study, possible vascular dementia (PVD) was defined by the combined presence of his-
tory of stroke and dementia. To estimate prevalence, n = 84 cases in the 2012 PVD group were
considered. The incident PVD group (n = 75) included n = 44 new cases of stroke with demen-
tia and n = 31 cases with stoke history who were cognitively normal at baseline but met criteria
for dementia at follow-up. Sociodemographic and health characteristics were not different
between these two groups (S1 Table).
Fig 2. Flowchart of sample selection at follow-up (MHAS 2015).
https://doi.org/10.1371/journal.pone.0253856.g002
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The cognitively normal group was defined following the criteria described above based on
cognitive domain scores for self-respondents and IQCODE for proxy respondents. For preva-
lence and incidence analyses we included cognitively normal individuals without stroke his-
tory (2012, n = 13,899 and 2015, n = 11,540, respectively).
Cognitively normal cases with stroke and incident dementia cases without stroke were
excluded from the analyses.
Covariates
Sociodemographic characteristics: sex, age as continuous or categorical (50–64, 65–74,� 75),
years of education as continuous or categorical (0, 1 to 6,� 7) following the formative periods
in the Mexican education system, and (0 to 3,� 4) to classify those in the lowest quartile.
Cardiovascular conditions were self-reported derived from the question: Has a medical doc-
tor diagnosed you with: diabetes, hypertension, heart attack or dyslipidemia? We used each dis-
ease categorically (yes-no) and as a continuous variable from the sum of all cardiovascular
conditions.
Depressive symptoms: the MHAS includes a modified version of the Center for Epidemio-
logical Studies-Depression (CES-D) with nine items (yes/no). We classified respondents with a
score�5 as clinically significant depressive symptoms based on a clinical validation study [26].
Global cognition was constructed as the standardized composite score of the CCCE (sum of
scores from each domain) for self-respondents and the IQCODE for proxy respondents.
Statistical analysis
To examine differences in covariates between diagnostic groups at baseline and follow-up, t-
test for continuous variables and Chi-square test for categorical variables, were used. For esti-
mating prevalence and incidence rates the MHAS sampling weights were used [19]. Prevalence
rates of PVD were stratified by sex, age, and education. Estimation of total age- and sex-
adjusted rates, using data from the Mexican census 2010 as the standard population, was per-
formed [27]. A binomial logistic regression model was used to analyze the association of socio-
demographic factors (sex, age, and education), cardiovascular conditions (hypertension,
diabetes, and heart attack) on the likelihood of PVD at baseline. For the estimation of inci-
dence rates of PVD, the total time contributed by all participants (person-years) was calculated
as follows: responders who remained cognitively normal at follow-up or were present, but
refused to participate contributed 3 years (time between MHAS waves 2012 and 2015); those
who were lost at follow-up were assigned a contribution of 1.5 years as the mid-point between
baseline and follow-up assessment; time contributed by decedents varied depending on the
year of death reported by the next of kin at follow-up; time until onset of vascular dementia
was defined as the mid-point between baseline and follow-up. The incidence rate of PVD was
defined as the number of new (incident) cases during study follow-up divided by the person-
time-at risk. To examine baseline predictors of attrition, logistic regression models for each
source of attrition: decedents vs. responders, lost vs. responders, and refusals vs. responders,
were used (S2 Table). Inverse probability weights (IPW) were employed to account for death
and other sources of attrition as competing risks for VaD in the analyses of risk factors [28].
Weights were based on the inverse probability of being observed at follow-up and thus of
being alive and uncensored. The rationale behind these weights is that respondents with simi-
lar characteristics at baseline to those missing at follow-up, are up-weighted. The probability of
being uncensored at follow-up, for each source of attrition (decedents, lost and refusal) versus
those alive (completers), was modeled using a logistic regression adjusting for baseline covari-
ates that had shown to influence attrition: sex, age, education, residence (urban-rural), self-
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reported diabetes, hypertension, heart attack, and global cognition. Later, the inverse probabil-
ity weight of survival (1/predicted probability) and the cumulative probability as the product
of weights was calculated. Finally, an evaluation of the association between baseline covariates
and PVD using IPA-weighted generalized estimating equations (GEE) regression model, was
performed. Statistical analyses were using SPSS software for Windows (SPSS Inc., Chicago, IL
version 25.0).
Results
Table 1 provides characteristics of the samples at baseline and follow-up stratified by cognitive
status. At baseline, participants with PVD had a mean age of 75.5 (SD 9.5) years, 52.4% were
female, and the mean educational level was 4.3 years (SD 4.5). We observed that those with
PVD (n = 84) were eleven years older than those in the normal diagnostic group. Persons aged
75 years or older comprise one-half of those with PVD. Sex distribution was not different
between groups. On average, PVD individuals had 1.4 years of education less than their nor-
mal counterparts, with a significantly lower proportion in the 7+ years of education (17.9%).
Table 1. Characteristics of the MHAS sample at baseline (2012) and follow-up (2015) by diagnostic group.










Mean (SD) Mean (SD) Mean (SD) Mean (SD)
n (%) n (%) n (%) n (%)
Age, Mean (SD) 64.8 (9.5) 75.5 (9.5) >.001 66.8 (9.2) 75.3 (11.2) >.001
50–59 years 4583 (33.0) 6 (7.1) >.001 3014 (26.1) 7 (9.3) >.001
60–69 years 5221 (37.6) 14 (16.7) >.001 4359 (37.8) 21 (28.0) .082
70–79 years 2913 (21.0) 40 (47.6) >.001 2981 (28.8) 19 (25.3) .922
80 + years 1182 (8.5) 24 (28.6) >.001 1186 (10.3) 28 (37.3) >.001
Sex (female) 7831 (56.3) 44 (52.4) .466 6551 (56.8) 43 (57.3) .917
Education, years
(SD)
5.7 (4.7) 4.3 (4.5) >.001 5.7 (4.6) 3.2 (4.4) >.001
No education 2456 (17.7) 20 (23.8) .142 1959 (17.0) 26 (34.7) >.001
1 to 6 years 7167 (51.6) 49 (58.3) .216 6004 (52.0) 40 (53.3) .822
7 + years 4276 (30.8) 15 (17.9) .011 3577 (31.0) 9 (12.0) >.001
Hypertension 5928 (42.7) 54 (64.3) >.001 5449 (47.3) 53 (70.7) >.001
Diabetes 3107 (22.4) 25 (29.8) .105 2839 (24.6) 25 (33.3) .082
Heart attack 446 (3.2) 17 (20.2) >.001 397 (3.4) 13 (17.3) .>001
Vascular conditions� 0.7 (0.8) 1.1 (0.9) >.001 0.8 (0.8) 1.2 (0.9) >.001
Depressive
symptoms��
4066 (31.1) 18 (64.3) >.001 3272 (29.4) 29 (70.7) >.001
Global cognition 0.1 (0.9) -1.3 (0.8) >.001 0.1 (1.0) -1.2 (0.8) >.001
Self-respondents 13068 (94) 28 (33.3) >.001 11122 (96.4) 41 (54.7) >.001
Proxy respondents 831 (6.0) 56 (66.7) >.001 418 (3.6) 34 (45.3) >.001
P-value from t-test for continuous variables and Chi-square for categorical variables. Values in parentheses are weighted percentages derived using the MHAS sampling
weights.
MHAS = Mexican Health and Aging Study.
�Vascular conditions = sum of hypertension, diabetes, and heart attack.
��Significant depressive symptoms (�5) are presented for self-respondents only (2012 n = 13096; 2015 n = 11162), proxy respondents did not complete the depressive
symptoms scale based on the study questionnaire.
https://doi.org/10.1371/journal.pone.0253856.t001
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In addition, hypertension (64.3%) and heart attack (20.2%) were the most frequent cardiovas-
cular conditions among PVD individuals (p>.001). Still in the PVD group, diabetes rates were
higher (29.8% vs. 22.4%), but not statistically significant (p = 0.105). Excluding stroke, individ-
uals with PVD had on average 1.1 (SD 0.9) vascular conditions compared to 0.7 (SD 0.8) in the
cognitively normal group (p< .001). For the analysis of depressive symptoms only self-respon-
dents (n = 28) were included given that proxy participants did not complete the depression
scale. The proportion of individuals with significant depressive symptoms in the PVD group
(64.3%) was twice as high as their normal counterparts (31.1%). Global cognition scores were
significantly lower (-1.3, SD 0.8) in the PVD group compared to normal individuals (0.1, SD
0.9) (p< .001). Regarding the type of interview through which participants completed the
MHAS survey, two-thirds of the PVD sample were proxy respondents, compared to 6% of the
normal sample (p< .001).
At follow-up (Table 1), participants with incident PVD (n = 75) showed similar characteris-
tics as the prevalent baseline PVD group. Compared to those cognitively normal, incident
PVD adults were on average 8.5 years older, more than half of the group was in the oldest
group (�75years); they were 2.5 years less educated with no education in nearly 35% of the
group. Rates of hypertension (70.7% vs.47.3%) and heart attack (17.3% vs. 3.4%) were signifi-
cantly higher (p< .001). Diabetes was also higher (33.3% vs. 24.6%) in the incident PVD
group but the difference did not reach statistical significance (p = 0.082). On average, the inci-
dent PVD group had 1.2 (SD 0.9) cardiovascular conditions (excluding stroke) while those
cognitively normal had 0.8 (SD 0.8) (p< .001). Considering self-respondents only (n = 67),
the proportion of individuals with significant depressive symptoms was significantly higher
among incident PVD individuals (70.7%) compared to the normal group (29.4%) (p< .001).
On average, global cognition scores were significantly lower (-1.2 SD 0.8) in the incident PVD
group compared to normal individuals (0.1 SD 1.0) (p< .001). Finally, the proportion of the
incident PVD sample in MHAS represented by a proxy respondent was 45.3% vs. 3.6% com-
pared to the cognitively normal sample (p<0.001)
Table 2 provides prevalence rates of PVD for men and women by age, sex, and education.
The total crude prevalence of PVD was 0.6% (95% CI, 0.5–0.8). Prevalence increased with age
reaching 2.0% (95% CI, 1.3–2.9) among individuals aged 80 and older, and decreased with
Table 2. Prevalence estimates of possible vascular dementia by sex, age, and education from the MHAS (2012).
Total Males Females
Prevalence estimate 95% CI Prevalence estimate 95% CI Prevalence estimate 95% CI
Age, y
50–59 0.1 (0.1–0.3a) 0.3 (0.2–0.7) 0.0 -
60–69 0.3 (0.2–0.5) 0.2 (0.1–0.5) 0.3 (0.1–0.6)
70–79 1.4 (1.0–1.8) 1.4 (0.9–2.2) 1.3 (0.9–2.0)
80+ 2.0 (1.3–2.9) 1.6 (0.8–3.0) 2.3 (0.1–4.0)
Education, y
0 0.8 (0.5–1.2) 0.9 (0.5–1.2) 0.7 (0.4–1.3)
1–6 0.7 (0.5–0.9) 0.7 (0.4–1.0) 0.7 (0.5–1.0)
7+ 0.3 (0.2–0.6) 0.5 (0.3–0.9) 0.2 (0.1–0.5)
Total crude 0.6 (0.5–0.8) 0.7 (0.5–0.9) 0.6 (0.4–0.8)
Total standardized� 0.5 (0.5–0.5b) 0.5 (0.5–0.6) 0.5 (0.5–0.5c)
MHAS = Mexican Health and Aging Study. CI = confidence interval. Values are weighted percentages (95% CI) derived using the MHAS sampling weights.
�Standardized = age- and sex-standardized to the Mexican population (2010), a: (0.06–0.28), b: (0.50–0.51), c: (0.48–0.50).
https://doi.org/10.1371/journal.pone.0253856.t002
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higher educational level from 0.8 (95% CI, 0.5–1.2) among those with no schooling, to 0.3%
(95% CI, 0.2–0.6) for those with 7 or more years of education. Sex differences were only signif-
icant among the youngest group (50 to 59 years) with 6 cases for men and no cases for women.
We found an overall age- and sex-adjusted PVD prevalence of 0.5 with no variations between
males and females.
Table 3 shows rates of incident PVD by sex and age. A total of 87 new cases comprises 75
observed individuals and 12 estimated cases from the different sources of attrition (dece-
dents = 8, lost = 3, and refuse = 1). Eighty-seven new cases represented an overall 2.2 (95% CI,
1.7–2.6) incidence rate of PVD per 1,000 person-years, the observed 75 cases represented an
incidence rate of 1.9 (95% CI, 1.5–2.5). Incidence increased progressively with age, reaching
an overall rate of 9.4 (95% CI, 6.3–13.6) per 1,000 person-years for individuals aged>80 years.
Total crude incidence rates of PVD were not different between males 2.2 (95% CI, 1.5–2.9)
and females 2.2 (95% CI 1.6–2.8). Although, increasing rates of incident vascular dementia
with age were slightly higher for females than males between ages 60 to 79 years, at age 80,
males showed a significant increase with a rate of 12.3 (95% CI, 7.2–19.7) per 1,000 person-
years compared to females who had a rate of 7.0 (95% CI, 3.5–12.4). We found an overall stan-
dardized age- and sex-adjusted PVD incidence of 2.0 with no variations between males and
females.
Table 4 shows the results of the full logistic models predicting incident PVD using GEE
with IPA-weights to account for attrition. The first model includes all individuals who partici-
pated in the survey through direct and proxy interviews (n = 11,615). We estimated a second
model for self-respondents only (n = 11,039) to analyze the association of depressive symp-
toms in 67 incident cases of PVD. Results showed that being male tended to be associated with
a higher risk of PVD, but estimates were only marginally significant (p = 0.081) among self-
respondents (OR 1.6, 95% CI, 0.9–2.7). At age 75 years and older individuals had 3.6 greater
odds of incident PVD compared to the youngest group (50–64 years). Being in the lowest
quartile of the education distribution (0–3 years) increased odds of incident PVD (OR 2.8,
95% CI, 1.5–5.2). The presence of hypertension (OR 2.6, 95% CI, 1.6–4.4), lower global cogni-
tion (OR 0.7, 95% CI, 0.5–1.0), and depressive symptoms (OR 2.6, 95% CI, 1.5–4.3) at baseline
were associated with increased risk of incident PVD.















50–59 13714 9 0.6 (0.3–
1.2)
5253 5 0.8 (0.0–
1.9)
8461 4 0.5 (0.1–
1.2)
60–69 15327 27 1.8 (1.2–
2.5)
7097 9 1.3 (0.1–
2.4)
8230 18 2.3 (1.4–
3.6)
70–79 8260 23 2.7 (1.8–
4.2)
3826 8 2.1 (0.1–
4.1)
4433 15 3.2 (1.7–
5.3)
80+ 2964 28 9.4 (6.3–
13.6)
1383 17 12.3 (7.2–
19.7)
1581 11 7.0 (3.5–
12.4)
Total crude 40264 87 2.2 (1.7–
2.6)
17559 38 2.2 (1.5–
2.9)




- - 2.0 (1.3–
2.7)
- - 2.0 (0.1–
3.0)
- - 2.0 (1.0–
2.9)
CI = confidence intervals; MHAS = Mexican Health and Aging Study. Values are weighted percentages (95% CI) derived using the MHAS sampling weights.
�Standardized = age- and sex-standardized to the Mexican population (2010).
https://doi.org/10.1371/journal.pone.0253856.t003
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Discussion
The prevalence of PVD in Mexican adults aged 50 years or older in the 2012-MHAS wave was
0.6% (95% CI, 0.5–0.8). A systematic analysis performed by Kalaria et. al [10], reporting VaD
prevalence in developing countries, also found low VaD estimates; 0.7% (95 CI, 0.1–1.3) in an
analysis of four studies in Taiwan where there is no mention of neuroimaging data and 1.1%
(95% CI, 0.2–1.9) in a sub analysis of five rural and urban studies in India, where only two
studies [29, 30] made use of brain imaging. In this same systematic analysis, authors reviewed
data from 12 centers and concluded that only 26% of cases of dementia fulfilled the National
Institute of Neurological Disorders and Stroke and Association Internationale pour la Recher-
ché et l’Enseignement en Neurosciences (NINDS-AIREN) criteria for VaD [31]. Thus, a higher
2.1% (95% CI; 1.6–2.7) prevalence was found in Venezuela [32] and even a 6% frequency was
reported in another study in Israel [33]. The latter used the Diagnostic and Statistical Manual
of Mental Disorders Fourth Edition (DSM-IV) criteria [34] for dementia diagnosis and made
VaD diagnosis at hospital discharge after stroke, while the Maracaibo study used the NIND-
S-AIREN criteria [31] for VaD, included several more neuropsychological cognitive tests, and
reported 67% access to neuroimaging data [32].
Age is the main risk factor for any kind of dementia, including cognitive impairment of
vascular origin. Based on results from the Maracaibo study in Latin America, Molero et al.
[32] also found an increasing pattern of VaD with age, with a frequency of 0.2% (95% CI,
0.1–0.7), 2.0% (95% CI, 1.8–3.3), and 5.2% (95% CI, 3.4–7.8) in adults aged 55–64, 65–74,
and 75–84, respectively, which is comparable to our findings. We also found no significant sex
variations for PVD prevalence, which is similar to what other Latin-American studies found
[11, 32].
Table 4. Generalized estimation equations regression models for predictors of possible vascular dementia using IPA-weights.
Incident Possible Incident Possible
Vascular Dementia�1 Vascular Dementia�2
Self and Proxy Respondents Self-Respondents
Baseline predictors OR p-value 95% CI OR p-value 95% CI
Sex (male) 1.3 .278 (0.8–2.1) 1.6 .081 (0.9–2.7)
Age
• 50–64 (ref) 1 1
• 65–74 1.1 .792 (0.6–2.1) 1.0 .950 (0.5–3.7)
• 75 + 3.6 >.001 (1.9–6.9) 2.7 .005 (1.3–5.3)
Education
• 0 to 3 2.8 >.001 (1.5–5.2) 2.0 .025 (1.1–3.7)
• 4 or more (ref) 1 1
Diabetes 1.6 .084 (0.9–2.5) 1.4 .277 (0.8–2.3)
Heart Attack 1.1 .936 (0.3–3.6) 0.7 .566 (0.2–2.9)
Hypertension 2.6 >.001 (1.6–4.4) 2.3 .003 (1.3–4.0)
Global cognition 0.7 .036 (0.5–1.0) 0.6 .003 (0.4–0.8)
Depressive Symptoms NA NA 2.6 >.001 (1.5–4.3)
Observations 11615 11039
�1 Estimates considering all cases of incident possible vascular dementia (PVD, n = 75)
�2 Estimates considering cases of incident PVD with information on depressive symptoms (PVD. n = 67) and excluding proxy respondents who did not complete the
depressive symptoms scale based on the proxy study questionnaire. IPA = inverse-probability-of-attrition; OR = odd ratio; CI = confidence interval; MHAS = Mexican
Health and Aging Study; OR = odd ratio.
https://doi.org/10.1371/journal.pone.0253856.t004
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In the present study PVD prevalence decreased from 0.8 (95% CI, 0.5–1.2) among individu-
als with no education, to 0.3% (95% CI, 0.2–0.6) for those with 7 or more years of education. A
systematic review reported that the presence of lower educational level increased the risk of
VaD 2.5 times (OR 2.5, 95% CI, 1.8–3.4, p< .001) [5]. Similarly, and after adjusting for con-
founding cardiovascular variables, the Rotterdam Study [35] found that only the least educated
(primary education) were at risk for VaD (RR: 2.1, 95% CI, 1.0–4.5). A lack of cognitive
reserve, where pre-existing mechanisms allow for neural compensation and favor resilience
when coping with the damage caused by vascular pathology, can be a possible explanation in
situations where a lower educational level is associated with greater dementia risk [36, 37].
Our rate for PVD incidence [2.2 (95% CI, 1.7–2.6)] was lower than that reported in the
Maracaibo study [13], in which a 3.4 (95% CI, 2.2–4.9) per 1000 person-years rate was found.
Access to neuroimaging was substantial in this last study, which could again explain the under-
estimation of VaD cases found in our study, particularly involving subcortical disease, small
lacunar brain infarctions, and mixed dementia cases, which are considered as part of the
umbrella of diagnostic possibilities for VaD [17]. Another study in the UK [12], which
described a lower VaD incidence rate compared to our findings [0.99/1,000 person-years (95%
CI, 0.96–1.02)], used an algorithm to identify individuals’ first-time VaD diagnosis based on
DSM-IV [34], NINCDS-ADRDA [38] or NINDS-AIREN [31] dementia criteria. Only 15% of
participants in this last study complied with diagnosis after neuroimaging. Methodological dif-
ferences between studies, such as the use of different diagnostic criteria, the inclusion of addi-
tional cognitive evaluation tests, and neuroimaging availability, could account for variability in
results.
An increasing VaD incidence with age of 0.8 (95% CI, 0.2–2.3), 3.8 (95% CI, 1.9–6.9), and
8.9 (95% CI, 4.1–16.9)/1,000 person-years, in adults 55–64, 64–74, and 75–84 years of age,
respectively, was described by Maestre et.al [13]. These findings are comparable to our study,
given that incidence rates reached an overall 9.4 per 1,000 person-years in individuals aged
>80 years. We also observed that males aged 80 years or older, showed greater incidence rates
when compared to females [12.3 (95% CI, 7.2–19.7) vs 7.0 (95% CI, 3.5–12.4) per 1,000 per-
son-years], which is also consistent with what other studies have shown [12, 14, 39].
The presence of depressive symptoms (OR = 2.6, 95% CI, 1.5–4.3) and hypertension
(OR = 2.6, 95% CI, 1.6–4.4) at baseline were associated with an increased risk of incident PVD.
It has been proposed that late life-depression is a risk factor for VaD as it is for AD [1]. A met-
analysis [40] reported a 2.5 (95% CI, 1.8–3.6) and 1.7 (95% CI, 1.4–1.9) greater risk for VaD
and AD, respectively, associated with late-life depression. Moreover, poorer health and a
higher burden of cardiovascular and cerebrovascular disease have also been associated to
depression in older age [41, 42]. Barnes, et.al., in a retrospective cohort study found that
chronic depression during the life course may be associated with an increased risk of dementia,
particularly VaD [43]. Vascular abnormalities, specifically white matter changes and small ves-
sel disease possibly playing a contributing role for dementia development, have been observed
on brain imaging of depressed patients [44]. Other studies have found similar results concern-
ing high blood pressure and VaD, with an OR of 2.0 (95% CI, 1.3–2.9) in the Hisayama study
[14] and 1.2 (95% CI, 1.1–1.3) in a report by Imfeld et.al [12]. Hypertension is a major risk fac-
tor for stroke, thus linking it to VCI [7]. Recent reports have found that high blood pressure
throughout midlife, increases the risk of dementia alone, even without stroke [6].
We acknowledge several limitations. First, information was obtained through a survey,
with results that can only be applied to the Mexican population. Due to the nature of the sur-
vey’s IADLs evaluation, a clear differentiation between disability due to stroke complications
or because of cognitive impairment alone, is not allowed. Second, as in most epidemiological sur-
veys, neuroimaging studies were not systematically performed in the MHAS. The exclusion of
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new dementia cases without a history of stroke but with small vessel disease or silent lacunar
strokes that can be identified through neuroimaging, could have also played an important role in
the underestimation of VaD cases. Third, the cognitive evaluation test used in the MHAS,
although proper in a cross-cultural context, could have also contributed to an underestimation of
cases, since its use does not allow a clear identification of subcortical cognitive domains. Lastly,
two-thirds of the sample included in the PVD group were diagnosed using answers of proxy
respondents, which may also have made PVD criterion less sensitive for detecting new cases.
One of the strengths of our study is that it is the first study that shows PVD incidence rates
in a large sample of Mexican residents. It is a longitudinal, representative, study that includes
adults 50 years or older and shows an overview of important sociodemographic risk factors
that mirror the health situation faced in developing countries, where educational policies,
health behaviors, and health care practices might be different from that in high-income coun-
tries. Additionally, common cardiovascular risk factors are present predominantly in Latin
America, highlighting the need for prevention strategies [45].
Conclusions
These data provide new estimates of PVD prevalence and incidence in the Mexican popula-
tion. Males aged 80 years or older showed a greater incidence rate when compared to females,
which is comparable to the mean of previous incidence estimates from other studies. Vascular
dementia prevention strategies should focus on potentially modifiable risk factors.
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S1 Table. General characteristics of incident possible vascular dementia by time of stroke
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results of the full logistic regression models for each source of attrition compared to responders.
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